4.5 Editorial Material

Additive Manufacturing Can Assist in the Fight Against COVID-19 and Other Pandemics and Impact on the Global Supply Chain

期刊

3D PRINTING AND ADDITIVE MANUFACTURING
卷 7, 期 3, 页码 100-103

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/3dp.2020.0106

关键词

3D printing; additive manufacturing; COVID-19; medical devices; pandemic; supply chain

向作者/读者索取更多资源

The high demand on medical devices and personal protective equipment (PPE) during the COVID-19 crisis left millions of health care professionals unprotected in the middle of this situation, as governments around the world were not prepared for such pandemic. The three-dimensional printing (3DP) community, from universities to 3DP enthusiasts with printers at home, was there to support hospitals from day 1 on this demand by providing PPE and other medical supplies (e.g., face shields and valves for respiratory machines). This editorial covers the importance of 3DP in the fight against COVID-19 and how this can be used to tackle potential pandemics and support the supply chain.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Development of 3D-printed subcutaneous implants using concentrated polymer/drug solutions

Camila J. Picco, Emilia Utomo, Andrea McClean, Juan Dominguez-Robles, Qonita Kurnia Anjani, Fabiana Volpe-Zanutto, Peter E. McKenna, Jonathan G. Acheson, Dessislava Malinova, Ryan F. Donnelly, Eneko Larraneta

Summary: Implantable drug-eluting devices have the potential to improve treatment of chronic conditions by providing sustained therapeutic effects and reducing pill burden for patients. The use of modern technologies like 3D printing allows for the production of customizable devices. In this study, subcutaneous implants loaded with olanzapine were formulated using the robocasting technique and demonstrated sustained drug release over a period of 200 days.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Correction Pharmacology & Pharmacy

Development of intranasal implantable devices for schizophrenia treatment (Vol624, 122061 2021)

Emilia Utomo, Juan Dominguez-Robles, Natalia Moreno-Castellanos, Sarah A. Stewart, Camila J. Picco, Qonita Kurnia Anjani, Jon Ander Simon, Ivan Penuelas, Ryan F. Donnelly, Eneko Larraneta

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

3D-printed long-acting 5-fluorouracil implant to prevent conjunctival fibrosis in glaucoma

Nicole Ioannou, Jinyuan Luo, Mengqi Qin, Matteo Di Luca, Essyrose Mathew, Aristides D. Tagalakis, Dimitrios A. Lamprou, Cynthia Yu-Wai-Man

Summary: A sustained release 5-FU implant composed of PCL and CS was fabricated using 3D printing technology for preventing conjunctival fibrosis after glaucoma surgery. The implant released 5-FU steadily over 8 weeks and effectively suppressed fibroblast contractility. It exhibited biocompatibility, smooth surface, and degradability.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

The manufacturing of 3D-printed microfluidic chips to analyse the effect upon particle size during the synthesis of lipid nanoparticles

Edward Weaver, Essyrose Mathew, Jay Caldwell, Andrew Hooker, Shahid Uddin, Dimitrios A. Lamprou

Summary: In this study, a UV LCD printer was used to produce microfluidic chips for liposomal synthesis, and the limitations of UV LCD printing in terms of resolution and print speed optimization were tested. By varying channel parameters, the essential properties for optimal liposomal formulation were investigated, and liposomes with sizes of approximately 120 nm and polydispersity index values of <= 0.12 were successfully synthesized. The influence of total flow rates and lipid choice on microfluidic setup optimization was also investigated in depth.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2023)

Review Chemistry, Medicinal

Combining 3D Printing and Microfluidic Techniques: A Powerful Synergy for Nanomedicine

Federica Sommonte, Nunzio Denora, Dimitrios A. Lamprou

Summary: Nanomedicine has developed rapidly in recent years for finding new therapies to treat challenging diseases. Microfluidic technology (MF) and additive manufacturing (AM) have gained popularity in the life science field, offering various benefits and drawbacks. By optimizing operational parameters, MF and AM can overcome existing limitations and their combination can provide highly-customizable and cost-effective solutions. This collaboration between MF and AM shows promising potential for impactful innovation in the near future.

PHARMACEUTICALS (2023)

Review Pharmacology & Pharmacy

Drug loaded implantable devices to treat cardiovascular disease

Masoud Adhami, Niamh K. Martin, Ciara Maguire, Aaron J. Courtenay, Ryan F. Donnelly, Juan Dominguez-Robles, Eneko Larraneta

Summary: Cardiovascular diseases are the leading cause of death globally. Drug eluting implants, that provide accurate drug release and minimize adverse side effects, have the potential for significant advancements in the treatment of these diseases.

EXPERT OPINION ON DRUG DELIVERY (2023)

Article Chemistry, Multidisciplinary

Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride

Li Zhao, Lalitkumar K. Vora, Stephen A. Kelly, Linlin Li, Eneko Larraneta, Helen O. McCarthy, Ryan F. Donnelly

Summary: Antibiotic resistance is a serious health problem and is expected to worsen in the future. Researchers have developed a hydrogel-forming microarray patch system that can deliver antibiotics in a sustained manner.

JOURNAL OF CONTROLLED RELEASE (2023)

Editorial Material Instruments & Instrumentation

Drug formulation and delivery: a UK and Ireland perspective

Dimitrios Lamprou, Katie B. Ryan

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Instruments & Instrumentation

Urethane dimethacrylate-based photopolymerizable resins for stereolithography 3D printing: A physicochemical characterisation and biocompatibility evaluation

Giulia Pitzanti, Valentyn Mohylyuk, Francesca Corduas, Niall M. Byrne, Jonathan A. Coulter, Dimitrios A. Lamprou

Summary: This study successfully formulated photocurable resins suitable for tissue engineering and other biomedical applications by testing and evaluating different polymer resins.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Instruments & Instrumentation

Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles

Edward Weaver, Federica Sommonte, Andrew Hooker, Nunzio Denora, Shahid Uddin, Dimitrios A. Lamprou

Summary: A novel in-house method of microfluidic production of biologic-encapsulated SLNs is proposed, which allows for high encapsulation efficiencies of both large hydrophilic and small hydrophobic active pharmaceutical ingredients. The study provides useful insight into sustained kinetics through in vitro analysis, which is valuable for future in vivo studies.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Food Science & Technology

The Manufacturing and Characterisation of Eugenol-Enclosed Liposomes Produced by Microfluidic Method

Jessica Ghodke, Sotirios I. Ekonomou, Edward Weaver, Dimitrios Lamprou, Olena Doran, Alexandros Ch. Stratakos

Summary: Liposomes enclosing eugenol were prepared using microfluidics in this study. Different lipids and microfluidic chip designs were used for the liposomal formulation. The encapsulation efficiency, stability, and eugenol release rate of the liposomes were evaluated. The results showed that the liposomal formulations can be used as delivery vehicles to enhance food safety.
Article Green & Sustainable Science & Technology

Poly(caprolactone)/lignin-based 3D-printed dressings loaded with a novel combination of bioactive agents for wound-healing applications

Juan Dominguez-Robles, Elias Cuartas-Gomez, Sean Dynes, Emilia Utomo, Qonita Kurnia Anjani, Usanee Detamornrat, Ryan F. Donnelly, Natalia Moreno-Castellanos, Eneko Larraneta

Summary: Curcumin and lignin were combined with poly(caprolactone) to create 3D-printed wound dressings with antioxidant and antimicrobial properties. The dressings showed sustained release of DPA and CUR and demonstrated significant improvements in wound healing in animal studies. Histological examination also showed positive outcomes in terms of epithelization, inflammatory reaction, fibroblast proliferation, and neoangiogenesis.

SUSTAINABLE MATERIALS AND TECHNOLOGIES (2023)

Article Pharmacology & Pharmacy

Development of 3D-printed vaginal devices containing metronidazole for alternative bacterial vaginosis treatment

Emilia Utomo, Juan Dominguez-Robles, Qonita Kurnia Anjani, Camila J. Picco, Anna Korelidou, Erin Magee, Ryan F. Donnelly, Eneko Larraneta

Summary: Bacterial vaginosis (BV) is an abnormal condition caused by changes in the vaginal microbiota. Current treatment involves the use of antibiotics, but frequent application is needed. This research proposes a prolonged release of metronidazole (MTZ) using biodegradable and biocompatible polymers in the form of intravaginal devices, which can reduce the frequency of administration.

INTERNATIONAL JOURNAL OF PHARMACEUTICS-X (2023)

Article Instruments & Instrumentation

Clopidogrel-loaded vascular grafts prepared using digital light processing 3D printing

Masoud Adhami, Camila J. Picco, Usanee Detamornrat, Qonita K. Anjani, Victoria A. Cornelius, Pamela Robles-Martinez, Andriana Margariti, Ryan F. Donnelly, Juan Dominguez-Robles, Eneko Larraneta

Summary: Cardiovascular diseases are a leading cause of death worldwide and significantly impact quality of life. 3D-printed biodegradable vascular grafts loaded with a drug called clopidogrel were developed using digital light processing technology. These grafts provide sustained drug release, reduce platelet deposition, and create a supportive environment for cellular attachment, viability, and growth.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

暂无数据